




* Department of Pediatrics, Spaarne Hospital Haarlem, Haarlem, Netherlands
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands
Departments of Pediatric Immunology
|| Otorhinolaryngology, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, Netherlands
Background. Limited effectiveness of current treatment strategies for recurrent acute otitis media (RAOM) and increasing antibiotic resistance have diverted attention to prevention of AOM by vaccination. Pneumococcal vaccination for AOM seems to have only modest clinical efficacy. Thus far, the effects on health-related quality of life (HRQoL) or functional health status (FHS) have not been studied.
Objective. To assess the effect of vaccination on HRQoL or FHS.
Methods. In a double-blind, randomized, controlled trial, 383 children 1 to 7 years old with RAOM were vaccinated with either heptavalent pneumococcal conjugate vaccine followed by pneumococcal polysaccharide vaccine (pneumococcal group: n = 190) or with hepatitis A or B vaccines (control group: n = 193). Parents completed validated Dutch versions of 8 HRQoL and FHS instruments assessing generic FHS (Rand, Functional Status Questionnaire specific, and Functional Status Questionnaire generic), otitis mediaspecific FHS (OM-6), otitis mediaspecific child HRQoL (Numerical Rating Scale for Child), family functioning (Family Functioning Questionnaire), and otitis mediaspecific caregiver HRQoL (Numerical Rating Scale for Caregiver). Scores were compared at baseline and at 14 and 26 months' follow-up.
Results. At baseline, the average AOM incidence in the pneumococcal and control group was 5.0 (SD: 2.8) and 4.9 (SD: 2.6) episodes per year, respectively, with 38.4% and 36.8% having suffered from
6 episodes per year. AOM frequency decreased 4.4 episodes per year in both groups, with a considerable and comparable improvement in HRQoL and FHS. No substantial differences in HRQoL or FHS were found between the pneumococcal and the control group at baseline or at 14 or 26 months' follow-up.
Conclusion. Pneumococcal vaccination has no beneficial effect compared with control vaccination on either HRQoL or FHS in children 1 to 7 years old with RAOM.
Key Words: health-related quality of life acute otitis media recurrent acute otitis media functional health status pneumococcal vaccination
Abbreviations: OM, otitis media AOM, acute otitis media RAOM, recurrent acute otitis media HRQoL, health-related quality of life FHS, functional health status Rand, Rand general health rating index for children FSQ, Functional Status Questionnaire FFQ, Family Functioning Questionnaire NRS Caregiver, Numerical Rating Scale for Caregiver NRS Child, Numerical Rating Scale for Child MANOVA, multivariate analysis of variance
This article has been cited by other articles:
![]() |
S. C. Clarke Control of pneumococcal disease in the United Kingdom - the start of a new era. J. Med. Microbiol., August 1, 2006; 55(Pt 8): 975 - 980. [Abstract] [Full Text] [PDF] |
||||